Insider Trading
GOSS Stock | USD 0.66 0.04 5.71% |
Slightly above 63% of Gossamer Bio's investor base is looking to short. The analysis of the overall investor sentiment regarding Gossamer Bio suggests that many traders are alarmed. Gossamer Bio's investing sentiment can be driven by a variety of factors including economic data, Gossamer Bio's earnings reports, geopolitical events, and overall market trends.
Gossamer |
Filed transaction by Gossamer Bio Director: . Insider Public Trading
Read at macroaxis.com
Cash Flow Correlation
Gossamer Bio's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Gossamer Bio's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Gossamer Bio Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Gossamer Bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Gossamer Bio Fundamental Analysis
We analyze Gossamer Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gossamer Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gossamer Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Gossamer Bio is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Gossamer Bio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Gossamer Bio stock to make a market-neutral strategy. Peer analysis of Gossamer Bio could also be used in its relative valuation, which is a method of valuing Gossamer Bio by comparing valuation metrics with similar companies.
Peers
Gossamer Bio Related Equities
RNAZ | Transcode Therapeutics | 11.56 | ||||
PHIO | Phio Pharmaceuticals | 6.30 | ||||
ZURA | Zura Bio | 0.00 | ||||
SONN | Sonnet Biotherapeutics | 0.68 | ||||
ZVSA | ZyVersa Therapeutics | 0.87 | ||||
QNRX | Quoin Pharmaceuticals | 1.59 |
Additional Tools for Gossamer Stock Analysis
When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.